NanoVibronix Completes UroShield® Pilot Study at University of Michigan NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company specializing in portable ultrasonic therapeutic devices such as UroShield®, PainShield®, and WoundShield®, has announced the successful completion of the first phase of a…
Conference Preview: Avenacy Updates 2025 Strategy Ahead of J.P. Morgan Healthcare Event Avenacy, a specialty pharmaceutical company focused on providing critical injectable medications, has shared updates regarding its recent business achievements, financial performance for 2024, and strategic priorities for 2025.…
FDA Grants Fast Track to Star Therapeutics for VGA039 in VWD Star Therapeutics, a clinical-stage biotechnology company focused on developing cutting-edge antibodies, has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VGA039, an…
UK Grants Conditional Approval for Amgen’s Tarlatamab in SCLC Amgen has announced that its bispecific antibody, IMDYLLTRA® (tarlatamab), has received conditional marketing authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of adult patients with…
Esophagus Test TissueCypher® Receives NY State Approval, Announces Castle Biosciences Castle Biosciences, Inc. (Nasdaq: CSTL), a leading company in providing innovative tests to guide patient care, has announced that its TissueCypher® Barrett’s Esophagus test has been approved by the New…
Pipeline Drives Orbis Medicines to Raise EUR 90 Million in Series A Funding Orbis Medicines, a leader in oral macrocycle drug discovery, has successfully closed a EUR 90 million Series A funding round, bringing the company’s total capital raised to…
Appoints Giancarlo Benelli as Head of Europe at BeiGene BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company set to rebrand as BeOne Medicines Ltd., appoints Giancarlo Benelli as Senior Vice President and Head of Europe, effective…
Novosound Unveils First Ultrasound Blood Pressure Monitor at CES 2025 Novosound, a groundbreaking company in ultrasound sensor development, is poised to make history at CES 2025 in Las Vegas by unveiling its ultrasound blood pressure monitoring technology. This marks a…
Foot & Ankle: Fusion Orthopedics Strategically Expands Reach Fusion Orthopedics USA, LLC (“Fusion”) has announced the successful expansion of its product portfolio with the acquisition of Metalogix External Fixation Systems. This transition, which includes Metalogix’s operations, distribution, and hospital accounts,…
Gene Therapy: JCR Pharmaceuticals and Modalis Advance Research JCR Pharmaceuticals Co., Ltd. (TOKYO:4552) and Modalis Therapeutics Corporation (TOKYO:4883) have announced a major advancement in their joint research program aimed at developing a novel gene therapy for central nervous system (CNS)…
Heart Disease Awareness Raised with Free Heart & Kidney Screenings in Macon Care Access, a health and research company, is offering residents of Macon, Georgia, the opportunity to participate in its Heart & Kidney Health Screening initiative. This program aims…
GeneDx Appoints Bryan Dechairo as Chief Operating Officer GeneDx (Nasdaq: WGS), a leader in advancing health outcomes through genomic insights, has announced the appointment of Bryan Dechairo as Chief Operating Officer (COO), effective immediately. In this newly created role, Dechairo…